Photon Therapeutics is delighted to return to London Vet Show 2026, where visitors will have the opportunity to explore the latest developments in PhotonUVC Vet and learn how this innovative technology is being used in veterinary ophthalmology practices around the world. Over the past year, the company has continued to expand its global reach, strengthen clinical collaborations, and build the growing evidence base supporting the use of ultraviolet-C (UVC) technology in the management of challenging corneal infections.
At stand E35, delegates can experience live demonstrations of PhotonUVC Vet, and gain practical insights into integrating the technology into everyday clinical practice. Visitors will also be able to view exclusive presentations from Chris Dixon and members of the Photon Therapeutics Key Opinion Leader panel, sharing their experiences, perspectives, and clinical applications of the technology.
Photon Therapeutics is
returning to London Vet Show 2026 to showcase the progress made over the past
year in bringing its innovative UVC technology to veterinary professionals
around the world.
The PhotonUVC Vet is a
handheld device that delivers a precisely controlled, five-second exposure of
265nm ultraviolet-C light to the cornea. The non-contact technology is designed
to reduce microbial load and offers veterinary professionals an additional
approach to managing challenging corneal infections, with potential benefits
for antimicrobial stewardship.
Visitors to stand E35 will
be able to see live demonstrations throughout the show, experience the
technology for themselves and speak to the Photon Therapeutics team about how
it can be incorporated into clinical practice.
Delegates will also be among
the first to hear first-hand insights from veterinary ophthalmologist Chris
Dixon, with a video presentation exploring his experience of using PhotonUVC
Vet in practice.
The stand will also feature
video contributions from members of Photon Therapeutics' Key Opinion Leader
(KOL) panel, sharing their perspectives on the technology, its clinical
applications and its potential to support veterinary ophthalmology.
Over the past year, Photon
Therapeutics has continued to strengthen its position in the veterinary sector,
expanding its international reach and investing in its team to support
veterinary professionals adopting the technology.
The company has also
continued to build clinical evidence around UVC technology, including published
research examining the reduction of culturable corneal bacteria following
treatment with the PhotonUVC Vet.
With an expanding global
presence and increasing clinical experience of the technology, London Vet Show
provides an opportunity for Photon Therapeutics to share its progress and
engage with veterinary professionals interested in new approaches to ocular infection
management.
Visitors will also have the
chance to win some fantastic prizes, with Photon Therapeutics running a
competition on both days of the show. Each day, one lucky winner will receive a
pair of Apple AirPods, while a runner-up will win a Hotel Chocolat hamper to
share with their veterinary practice.
Visit Photon Therapeutics on
stand E35 at London Vet Show 2026 to see the PhotonUVC Vet in action, meet the
team, hear the latest clinical experiences and enter the competition for a
chance to win!